Santos da Silva Jorge
SEC insider (Form 3/4/5 filer). CIK 0001920509. Chief Executive Officer at MoonLake Immunotherapeutics (MLTX). 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 10, 2026. Located in ZUG.
Companies Santos da Silva Jorge has filed insider reports for
- MoonLake Immunotherapeutics (MLTX): Director, Officer, Chief Executive Officer
Santos da Silva Jorge
CIK: 0001920509
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MoonLake Immunotherapeutics
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 10, 2026MLTX
MoonLake Immunotherapeutics
SaleDirect68.3K shares at avg. $20.02$1.4M - Jul 9, 2026MLTX
MoonLake Immunotherapeutics
SaleDirect33.9K shares at avg. $20.01$679K - Jul 1, 2026MLTX
MoonLake Immunotherapeutics
SaleDirect47.8K shares at avg. $20.03$957K - Apr 13, 2026MLTX
MoonLake Immunotherapeutics
SaleDirect51.9K shares at avg. $18.23$946K - Apr 10, 2026MLTX
MoonLake Immunotherapeutics
SaleDirect98.1K shares at avg. $18.41$1.8M - Jan 7, 2026MLTX
MoonLake Immunotherapeutics
AwardDirectStock Option (Right to Buy)
520.3K shares- - Dec 19, 2025MLTX
MoonLake Immunotherapeutics
DispositionDirect196.3K shares- - Dec 19, 2025MLTX
MoonLake Immunotherapeutics
ConversionDirect196.3K shares- - Dec 9, 2025MLTX
MoonLake Immunotherapeutics
SaleDirect70K shares at avg. $14.49$1.0M - Dec 8, 2025MLTX
MoonLake Immunotherapeutics
SaleDirect130K shares at avg. $15.08$2.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 10, 2026 | MLTX MoonLake Immunotherapeutics | Sale | 68,289 | $20.02 | $1,367,146 | Direct |
| Jul 9, 2026 | MLTX MoonLake Immunotherapeutics | Sale | 33,936 | $20.01 | $679,059 | Direct |
| Jul 1, 2026 | MLTX MoonLake Immunotherapeutics | Sale | 47,775 | $20.03 | $956,933 | Direct |
| Apr 13, 2026 | MLTX MoonLake Immunotherapeutics | Sale | 51,873 | $18.23 | $945,645 | Direct |
| Apr 10, 2026 | MLTX MoonLake Immunotherapeutics | Sale | 98,127 | $18.41 | $1,806,518 | Direct |
| Jan 7, 2026 | MLTX MoonLake Immunotherapeutics | Award Stock Option (Right to Buy) | 520,342 | - | - | Direct |
| Dec 19, 2025 | MLTX MoonLake Immunotherapeutics | Disposition | 196,316 | - | - | Direct |
| Dec 19, 2025 | MLTX MoonLake Immunotherapeutics | Conversion | 196,316 | - | - | Direct |
| Dec 9, 2025 | MLTX MoonLake Immunotherapeutics | Sale | 70,000 | $14.49 | $1,014,300 | Direct |
| Dec 8, 2025 | MLTX MoonLake Immunotherapeutics | Sale | 130,000 | $15.08 | $1,960,400 | Direct |
1-10 of 11 transactions